156 related articles for article (PubMed ID: 35370781)
1. The Sphingolipid Inhibitors Ceranib-2 and SKI-II Reduce Measles Virus Replication in Primary Human Lymphocytes: Effects on mTORC1 Downstream Signaling.
Chithelen J; Franke H; Länder N; Grafen A; Schneider-Schaulies J
Front Physiol; 2022; 13():856143. PubMed ID: 35370781
[TBL] [Abstract][Full Text] [Related]
2. Use of Acid Ceramidase and Sphingosine Kinase Inhibitors as Antiviral Compounds Against Measles Virus Infection of Lymphocytes
Grafen A; Schumacher F; Chithelen J; Kleuser B; Beyersdorf N; Schneider-Schaulies J
Front Cell Dev Biol; 2019; 7():218. PubMed ID: 31632969
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia.
LeBlanc FR; Liu X; Hengst J; Fox T; Calvert V; Petricoin EF; Yun J; Feith DJ; Loughran TP
Cancer Biol Ther; 2015; 16(12):1830-40. PubMed ID: 26252351
[TBL] [Abstract][Full Text] [Related]
4. APOBEC3G-Regulated Host Factors Interfere with Measles Virus Replication: Role of REDD1 and Mammalian TORC1 Inhibition.
Tiwarekar V; Wohlfahrt J; Fehrholz M; Scholz CJ; Kneitz S; Schneider-Schaulies J
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925665
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective role of sphingolipid rheostat in excitotoxic retinal ganglion cell death.
Nakamura N; Honjo M; Yamagishi R; Kurano M; Yatomi Y; Watanabe S; Aihara M
Exp Eye Res; 2021 Jul; 208():108623. PubMed ID: 34022173
[TBL] [Abstract][Full Text] [Related]
6. Anticancer effect of acid ceramidase inhibitor ceranib-2 in human breast cancer cell lines MCF-7, MDA MB-231 by the activation of SAPK/JNK, p38 MAPK apoptotic pathways, inhibition of the Akt pathway, downregulation of ERα.
Vethakanraj HS; Sesurajan BP; Padmanaban VP; Jayaprakasam M; Murali S; Sekar AK
Anticancer Drugs; 2018 Jan; 29(1):50-60. PubMed ID: 29023248
[TBL] [Abstract][Full Text] [Related]
7. SphK1 inhibitor SKI II inhibits the proliferation of human hepatoma HepG2 cells via the Wnt5A/β-catenin signaling pathway.
Liu H; Zhang CX; Ma Y; He HW; Wang JP; Shao RG
Life Sci; 2016 Apr; 151():23-29. PubMed ID: 26944438
[TBL] [Abstract][Full Text] [Related]
8. SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo.
Yang L; Weng W; Sun ZX; Fu XJ; Ma J; Zhuang WF
Biochem Biophys Res Commun; 2015 May; 460(4):903-8. PubMed ID: 25824043
[TBL] [Abstract][Full Text] [Related]
9. 4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras proto-oncogenes in mice.
Wang C; Cigliano A; Jiang L; Li X; Fan B; Pilo MG; Liu Y; Gui B; Sini M; Smith JW; Dombrowski F; Calvisi DF; Evert M; Chen X
Hepatology; 2015 Jan; 61(1):200-13. PubMed ID: 25145583
[TBL] [Abstract][Full Text] [Related]
10. Targeting ceramide metabolic pathway induces apoptosis in human breast cancer cell lines.
Vethakanraj HS; Babu TA; Sudarsanan GB; Duraisamy PK; Ashok Kumar S
Biochem Biophys Res Commun; 2015 Aug; 464(3):833-9. PubMed ID: 26188095
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II.
Cingolani F; Casasampere M; Sanllehí P; Casas J; Bujons J; Fabrias G
J Lipid Res; 2014 Aug; 55(8):1711-20. PubMed ID: 24875537
[TBL] [Abstract][Full Text] [Related]
12. 4EBP-Dependent Signaling Supports West Nile Virus Growth and Protein Expression.
Shives KD; Massey AR; May NA; Morrison TE; Beckham JD
Viruses; 2016 Oct; 8(10):. PubMed ID: 27763553
[TBL] [Abstract][Full Text] [Related]
13. Examining impacts of ceranib-2 on the proliferation, morphology and ultrastructure of human breast cancer cells.
Vejselova D; Kutlu HM; Kuş G
Cytotechnology; 2016 Dec; 68(6):2721-2728. PubMed ID: 27380965
[TBL] [Abstract][Full Text] [Related]
14. The investigation of ceranib-2 on apoptosis and drug interaction with carboplatin in human non small cell lung cancer cells in vitro.
Yildiz-Ozer M; Oztopcu-Vatan P; Kus G
Cytotechnology; 2018 Feb; 70(1):387-396. PubMed ID: 29230631
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic and Apoptotic Impacts of Ceranib-2 on RAW 264.7 Macrophage Cells.
Alanyalı FS; Algı O
Anticancer Agents Med Chem; 2023; 23(20):2183-2188. PubMed ID: 36397616
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a ceramidase inhibitor (ceranib-2) with C2 ceramide and cisplatin on cytotoxicity and apoptosis of glioma cells.
Kuş G; Özkurt M; Öztopcu Vatan P; Erkasap N; Uyar R; Kabadere S
Turk J Biol; 2018; 42(3):259-265. PubMed ID: 30814888
[TBL] [Abstract][Full Text] [Related]
17. Human chorionic gonadotropin stimulates theca-interstitial cell proliferation and cell cycle regulatory proteins by a cAMP-dependent activation of AKT/mTORC1 signaling pathway.
Palaniappan M; Menon KM
Mol Endocrinol; 2010 Sep; 24(9):1782-93. PubMed ID: 20660299
[TBL] [Abstract][Full Text] [Related]
18. Increased milk protein synthesis in response to exogenous growth hormone is associated with changes in mechanistic (mammalian) target of rapamycin (mTOR)C1-dependent and independent cell signaling.
Sciascia Q; Pacheco D; McCoard SA
J Dairy Sci; 2013 Apr; 96(4):2327-2338. PubMed ID: 23462168
[TBL] [Abstract][Full Text] [Related]
19. A novel mode of action of the putative sphingosine kinase inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl) thiazole (SKI II): induction of lysosomal sphingosine kinase 1 degradation.
Ren S; Xin C; Pfeilschifter J; Huwiler A
Cell Physiol Biochem; 2010; 26(1):97-104. PubMed ID: 20502009
[TBL] [Abstract][Full Text] [Related]
20. The anti-ovarian cancer activity by WYE-132, a mTORC1/2 dual inhibitor.
Zhang D; Xia H; Zhang W; Fang B
Tumour Biol; 2016 Jan; 37(1):1327-36. PubMed ID: 26293898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]